These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7993000)

  • 1. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
    Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE
    Ann Intern Med; 1995 Jan; 122(2):81-9. PubMed ID: 7993000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
    Pillemer SR; Fowler SE; Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Clegg DO; Leisen JC; Cooper SM; Duncan H; Tuttleman M
    Arthritis Rheum; 1997 Mar; 40(3):419-25. PubMed ID: 9082927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiprilose hydrochloride for rheumatoid arthritis.
    Riskin WG; Gillings DB; Scarlett JA
    Ann Intern Med; 1989 Sep; 111(6):455-65. PubMed ID: 2672925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
    Kloppenburg M; Breedveld FC; Terwiel JP; Mallee C; Dijkmans BA
    Arthritis Rheum; 1994 May; 37(5):629-36. PubMed ID: 8185689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.
    Am J Med; 1995 Feb; 98(2):156-68. PubMed ID: 7847432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.
    Bluhm GB; Sharp JT; Tilley BC; Alarcon GS; Cooper SM; Pillemer SR; Clegg DO; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Leisen JC; Buckley L; Duncan H; Tuttleman M; Li S; Fowler SE
    J Rheumatol; 1997 Jul; 24(7):1295-302. PubMed ID: 9228128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
    Kremer JM; Genovese MC; Cannon GW; Caldwell JR; Cush JJ; Furst DE; Luggen ME; Keystone E; Weisman MH; Bensen WM; Kaine JL; Ruderman EM; Coleman P; Curtis DL; Kopp EJ; Kantor SM; Waltuck J; Lindsley HB; Markenson JA; Strand V; Crawford B; Fernando I; Simpson K; Bathon JM
    Ann Intern Med; 2002 Nov; 137(9):726-33. PubMed ID: 12416946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
    van Everdingen AA; Jacobs JW; Siewertsz Van Reesema DR; Bijlsma JW
    Ann Intern Med; 2002 Jan; 136(1):1-12. PubMed ID: 11777359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Haire CE; Palmer W; Drymalski W; Wees S; Blakely K; Churchill M; Eckhoff PJ; Weaver A; Doud D; Erikson N; Dietz F; Olson R; Maloley P; Klassen LW; Moore GF
    Arthritis Rheum; 1997 May; 40(5):842-8. PubMed ID: 9153544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocycline.
    Kloppenburg M; Dijkmans BA; Verweij CL; Breedveld FC
    Immunopharmacology; 1996 Mar; 31(2-3):163-9. PubMed ID: 8861742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
    Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Maximov A; Vorontsov I; Fink CW; Newman AJ; Cassidy JT; Zemel LS
    N Engl J Med; 1992 Apr; 326(16):1043-9. PubMed ID: 1549149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and risks of minocycline in rheumatoid arthritis.
    Langevitz P; Livneh A; Bank I; Pras M
    Drug Saf; 2000 May; 22(5):405-14. PubMed ID: 10830256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.
    Genovese MC; Jarosova K; Cieślak D; Alper J; Kivitz A; Hough DR; Maes P; Pineda L; Chen M; Zaidi F
    Arthritis Rheumatol; 2015 Jul; 67(7):1703-10. PubMed ID: 25779750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.